Regina Gary
Erlangen, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Prevention of CMV/EBV reactivation by double-specific T cells in patients after allogeneic stem cell transplantation: results from the randomized phase I/IIa MULTIVIR-01 study.
Journal: Frontiers in immunology
Published: July 02, 2023
Rescue therapy of antisynthetase syndrome with CD19-targeted CAR-T cells after failure of several B-cell depleting antibodies.
Journal: Rheumatology (Oxford, England)
Published: June 27, 2023
Author Correction: Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus.
Journal: Nature medicine
Published: November 04, 2022
Successful Generation of CD19 Chimeric Antigen Receptor T Cells from Patients with Advanced Systemic Lupus Erythematosus.
Journal: Transplantation and cellular therapy
Published: August 16, 2022
Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus.
Journal: Nature medicine
Published: July 04, 2022
Reconstitution of EBV-directed T cell immunity by adoptive transfer of peptide-stimulated T cells in a patient after allogeneic stem cell transplantation for AITL.
Journal: PLoS pathogens
Published: December 16, 2021
Impact of collection programs for the generation of monocyte apheresis products on product quality and composition as starting material for the generation of cellular therapeutics.
Journal: Transfusion
Published: February 05, 2018
Clinical-grade generation of peptide-stimulated CMV/EBV-specific T cells from G-CSF mobilized stem cell grafts.
Journal: Journal of translational medicine
Published: January 04, 2018
Donor CD4 T Cell Diversity Determines Virus Reactivation in Patients After HLA-Matched Allogeneic Stem Cell Transplantation.
Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Published: September 22, 2014
Advances in cellular therapy: 7th international symposium on the clinical use of cellular products, March 14 and 15, 2013, Erlangen, Germany.
Journal: Cancer immunology, immunotherapy : CII
Published: August 15, 2013
Last Updated: 09/26/2026